Insiders · Profile

Aperture Venture Partners IV, L.P.

10% owner at Trevi Therapeutics. Filing since 9 May 2019. CIK 0001659119

Company
Date
Role
Action
Shares
Amount
Of holding
9 May 2019
10% owner
Bought
112,000
$1.12M
48.1%
1 decision on file.